
The VP Strategic HR Business Partner (SHRBP) for the Chief Scientific Officer (CSO) is a strategic leadership role responsible for aligning people strategy with Evotec’s overarching goals, particularly in the realms of AI, innovation, Therapeutic Area expertise and scientific excellence. Reporting to the Head of HR Business Partners, this position serves as a trusted advisor to the CSO and their global leadership team, driving initiatives that enable Evotec’s success in cutting-edge, high-performance environments.
The GHRBP works closely with senior leaders to shape and define the company’s AI and innovation strategy from a people perspective, ensuring that talent, organizational structures, and culture enable the company’s scientific and technological ambitions. This role partners with HR Centers of Expertise (CoEs) and local HRBP Communities teams to implement integrated, data-driven HR solutions that foster business agility, drive transformation, and enhance Evotec’s position as a leader in partnership with the life sciences, AI, and biotech sectors.
Key Deliverables and Accountabilities
Strategic Partnership & Advisory
Collaboration & Stakeholder Management
Organizational Effectiveness & Transformation
Operational Excellence
Qualifications & Experience
Personal Attributes
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.

Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients.
Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing.
We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI.
We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.